[go: up one dir, main page]

WO2008121813A3 - Modulation of cytokine production - Google Patents

Modulation of cytokine production Download PDF

Info

Publication number
WO2008121813A3
WO2008121813A3 PCT/US2008/058648 US2008058648W WO2008121813A3 WO 2008121813 A3 WO2008121813 A3 WO 2008121813A3 US 2008058648 W US2008058648 W US 2008058648W WO 2008121813 A3 WO2008121813 A3 WO 2008121813A3
Authority
WO
WIPO (PCT)
Prior art keywords
cytokine production
modulation
duba
polypeptides
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/058648
Other languages
French (fr)
Other versions
WO2008121813A2 (en
Inventor
Vishva Dixit
Nobuhiko Kayagaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of WO2008121813A2 publication Critical patent/WO2008121813A2/en
Publication of WO2008121813A3 publication Critical patent/WO2008121813A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/19—Omega peptidases (3.4.19)
    • C12Y304/19012—Ubiquitinyl hydrolase 1 (3.4.19.12)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Methods of using DUBA polypeptides and nucleic acids in modulating cytokine production and in modulating immune response are provided. Methods of diagnosing and treating certain pathophysiological conditions using the DUBA polypeptides and nucleic acids of the invention are also provided.
PCT/US2008/058648 2007-03-30 2008-03-28 Modulation of cytokine production Ceased WO2008121813A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92090307P 2007-03-30 2007-03-30
US60/920,903 2007-03-30

Publications (2)

Publication Number Publication Date
WO2008121813A2 WO2008121813A2 (en) 2008-10-09
WO2008121813A3 true WO2008121813A3 (en) 2009-02-05

Family

ID=39808870

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/058648 Ceased WO2008121813A2 (en) 2007-03-30 2008-03-28 Modulation of cytokine production

Country Status (1)

Country Link
WO (1) WO2008121813A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007120334A2 (en) 2005-12-15 2007-10-25 Genentech, Inc. Methods and compositions for targeting polyubiquitin
JP5523345B2 (en) 2008-01-18 2014-06-18 ジェネンテック， インコーポレイテッド Methods and compositions targeting K63-linked polyubiquitin
CN102947335B (en) 2010-04-15 2018-11-06 基因泰克公司 Anti-polyubiquitin antibodies and methods of use
US9321844B2 (en) 2011-08-05 2016-04-26 Genentech, Inc. Anti-polyubiquitin antibodies

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005046452A2 (en) * 2003-11-10 2005-05-26 The Board Of Trustees Of The Leland Stanford Junior University A polypeptide complex that regulates cell cycle and anergy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005046452A2 (en) * 2003-11-10 2005-05-26 The Board Of Trustees Of The Leland Stanford Junior University A polypeptide complex that regulates cell cycle and anergy

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BALAKIREV MY ET AL: "Otubains: a new family of cysteine proteases in the ubiquitin pathway", EMBO REPORTS, XX, XX, vol. 4, no. 5, 18 April 2003 (2003-04-18), pages 517 - 522, XP002993680 *
KAYAGAKI NOBUHIKO ET AL: "DUBA: a deubiquitinase that regulates type I interferon production.", SCIENCE (NEW YORK, N.Y.) 7 DEC 2007, vol. 318, no. 5856, 7 December 2007 (2007-12-07), pages 1628 - 1632, XP002504119, ISSN: 1095-9203 *
KAYAGAKI NOBUHIKO ET AL: "DUBA: a deubiquitinase that regulates type I interferon production.", SCIENCE EXPRESS, vol. 318, 8 November 2007 (2007-11-08), XP002504186, Retrieved from the Internet <URL:www.sciencemag.org/cgi/content/full/1145918/DC1> [retrieved on 20081115] *
NIJMAN SEBASTIAN M B ET AL: "A genomic and functional inventory of deubiquitinating enzymes.", CELL 2 DEC 2005, vol. 123, no. 5, 2 December 2005 (2005-12-02), pages 773 - 786, XP002504120, ISSN: 0092-8674 *

Also Published As

Publication number Publication date
WO2008121813A2 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
WO2009058379A3 (en) Protein scaffolds
WO2006104615A3 (en) Influenza nucleic acids, polypeptides, and uses thereof
WO2010011735A3 (en) Modified bovine g-csf polypeptides and their uses
WO2009067636A3 (en) Modified insulin polypeptides and their uses
WO2009060418A3 (en) Transgenic plants and modulators for improved stress tolerance
ZA200904684B (en) Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them
WO2008028117A3 (en) Glp-2 mimetibodies, polypeptides, compositions, methods and uses
WO2009058564A3 (en) Immunosuppressive polypeptides and nucleic acids
WO2008140493A3 (en) Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof
WO2010020766A3 (en) Interleukin fusion polypeptides
WO2006133089A3 (en) Improved human interferon molecules and their uses
WO2010011944A3 (en) Protein screeing methods
WO2009036460A3 (en) Modified human apolipoprotein a-i polypeptides and their uses
WO2008104974A3 (en) Composition and methods for modulating cell proliferation and cell death
WO2008103947A3 (en) Activation of human antigen-presenting cells through clec-6
WO2008085900A3 (en) Methods for generating novel stabilized proteins
WO2007001264A3 (en) Method of making recombinant human antibodies for use in biosensor technology
WO2009102367A3 (en) Tight junction protein modulators and uses thereof
WO2014004540A8 (en) Method for engineering proteases and protein kinases
WO2007092777A3 (en) Cloning, characterization, and application of tnfrsf19 in neurological disorders
WO2008086035A3 (en) Split mutant hydrolase fusion reporter and uses thereof
WO2014150748A3 (en) Stabilized single human cd4 domains and fusion proteins
WO2007053731A3 (en) Expression of soluble factor viii proteins in bacteria
WO2012037215A3 (en) Recombinant yeast with improved ethanol tolerance and related methods of use
WO2010051056A3 (en) ANTI-FcεRI POLYPEPTIDES AND THEIR USES

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08744600

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08744600

Country of ref document: EP

Kind code of ref document: A2